Dr. Steve: do the risks of screening for prostate cancer outweigh benefits?

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

Remember those reports where the United States Preventative Services Task Force said that the risks of routine blood testing for prostate cancer, known as the PSA test, outweighed the benefits?

Well, it seems that fewer men are being screened these days as a result, and less early stage cancers are being detected. This could have serious complications.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.